Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 24, 2022 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma and EVERSANA Announce Acceptance of Abstract for Poster of Distinction Presentation at Digestive Disease Week (DDW) May 2022

SOLANA BEACH, Calif., and CHICAGO, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal...
February 17, 2022 08:30 ET | Source: Evoke Pharma, Inc.

GIMOTI® Commercialization Update

New Research Study Demonstrates Increased Acceptance Among Healthcare Providers Patient Testimonial Videos Detail Benefits Included and Available on GimotiRx.com Expanded Coverage with recent...
February 02, 2022 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma and EVERSANA Extend Commercialization Partnership to Further Support GIMOTI

SOLANA BEACH, Calif. and CHICAGO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company primarily focused on treatments for gastrointestinal (GI)...
January 04, 2022 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference

SOLANA BEACH, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (G.I.) diseases,...
November 10, 2021 16:05 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Reports Third Quarter 2021 Financial Results

SOLANA BEACH, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases,...
November 03, 2021 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma to Report Third Quarter 2021 Financial Results on November 10, 2021

SOLANA BEACH, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases,...
October 20, 2021 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma and EVERSANA Announce Positive Findings from GIMOTI® Market Research Study

Health care practitioners’ perception of nasal route of administration similar to IV; 92% intend to prescribe GIMOTI Evoke attending American College of Gastroenterology (ACG) Annual Conference in...
September 29, 2021 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma’s Commercial Partner EVERSANA, Receives PM360’s Trailblazer Initiative Award for Innovation in Healthcare Marketing for GIMOTI

Award for “Spray Away” Campaign seeking to drive patient and provider awareness for the novel nasal spray treatment of symptoms of Diabetic Gastroparesis SOLANA BEACH, Calif., Sept. 29, 2021 (GLOBE...
September 01, 2021 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference

SOLANA BEACH, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
August 12, 2021 16:05 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Reports Second Quarter 2021 Financial Results

Approximately 162% growth in product sales, 152% growth in prescriptions and 57% increase in new prescribers for Gimoti® Extends cash runway into third quarter of 2022 SOLANA BEACH, Calif., Aug....